Beata Bolewska
Impact in
- Hepatology top 10%
- Hepatitis C virus research
-
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- Hepatitis B Virus Studies 6
- Liver Disease Diagnosis and Treatment 6
-
- Hepatitis C virus research 8
- Co-authors
- Robert Flisiak (11 shared papers)Dorota Zarębska‐Michaluk (9 shared papers)Magdalena Rogalska (7 shared papers)Anna Piekarska (6 shared papers)Dorota Kozielewicz (7 shared papers)Marta Rorat (7 shared papers)Krzysztof Tomasiewicz (5 shared papers)Jerzy Jaroszewicz (6 shared papers)
- Journals
- Journal of Clinical Medicine (3 papers)Journal of Hepatology (2 papers)Cancers (1 paper)Viruses (1 paper)Journal of Medical Virology (1 paper)
- Partner nations
- PolandUnited StatesLithuania
In The Last Decade
Beata Bolewska
18 papers receiving 161 citations
Peers
Comparison fields: 5 of 43
- Hepatology 55
- Infectious Diseases 77
- Neurology 36
- Epidemiology 60
- Obstetrics and Gynecology 9
Countries citing papers authored by Beata Bolewska
This map shows the geographic impact of Beata Bolewska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beata Bolewska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beata Bolewska more than expected).
Fields of papers citing papers by Beata Bolewska
This network shows the impact of papers produced by Beata Bolewska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beata Bolewska. The network helps show where Beata Bolewska may publish in the future.
Co-authors
The 25 scholars most cited alongside Beata Bolewska, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 22 | |
| 2 | 2021 | 22 | |
| 3 | 2020 | 21 | |
| 4 | 2021 | 18 | |
| 5 | 2021 | 17 | |
| 6 | 2018 | 14 | |
| 7 | 2021 | 11 | |
| 8 | 2017 | 10 | |
| 9 | 2000 | 5 | |
| 10 | 2011 | 5 | |
| 11 | 2022 | 4 | |
| 12 | A multi-center open study to determine the effect of lamivudine on HBV DNA clearance and to assess the safety of the regimen in patients with chronic hepatitis B infection. | 2002 | 3 |
| 13 | 2024 | 2 | |
| 14 | 1999 | 2 | |
| 15 | 2016 | 2 | |
| 16 | [Procalcitonin as a diagnostic marker in systemic inflammatory response syndrome (SIRS) and sepsis]. | 2006 | 2 |
| 17 | [Diagnostic difficulties in febrile travellers returning from the tropics. Two cases of typhoid fever imported from India]. | 2002 | 1 |
| 18 | [Serum iron parameters in chronic hepatitis C patients and comparison of the results before and during antiviral treatment]. | 2005 | 1 |
About Beata Bolewska
Beata Bolewska is a scholar working on Epidemiology, Hepatology, Infectious Diseases, Neurology and Molecular Biology, having authored 18 papers that have together received 162 indexed citations. Recurring topics across this work include Hepatitis C virus research (8 papers), Hepatitis B Virus Studies (6 papers), COVID-19 Clinical Research Studies (6 papers), Liver Disease Diagnosis and Treatment (6 papers), Long-Term Effects of COVID-19 (5 papers), SARS-CoV-2 and COVID-19 Research (3 papers), HIV Research and Treatment (1 paper) and COVID-19 impact on air quality (1 paper). The work is most often cited by research in Hepatology (55 citations), Infectious Diseases (77 citations), Neurology (36 citations), Epidemiology (60 citations) and Obstetrics and Gynecology (9 citations). Beata Bolewska has collaborated with scholars based in Poland, United States and Lithuania. Frequent co-authors include Robert Flisiak, Dorota Zarębska‐Michaluk, Magdalena Rogalska, Anna Piekarska, Dorota Kozielewicz, Marta Rorat, Krzysztof Tomasiewicz, Jerzy Jaroszewicz, Justyna Kowalska and Magdalena Tudrujek‐Zdunek. Their work appears in journals such as Journal of Clinical Medicine, Journal of Hepatology, Cancers, Viruses and Journal of Medical Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.